Gary Hsich, MD

Appointed
2005

Education & Fellowships

Fellowship - Kennedy Krieger Institute
Neurology, post-doctoral fellow
Baltimore, MD
2005

Fellowship - Massachusetts General Hospital
Neurology Research Gene Therapy
Boston, MA
2004

Fellowship - Boston Children's Hospital
Child Neurology
Boston,, MA
2001

Residency - Children's Hospital of Philadelphia
Pediatrics
Philadelphia, PA
1998

Medical Education - Johns Hopkins University School of Medicine
Baltimore, MD
1996

Undergraduate - The John Hopkins University
Baltimore, MD
1991

Additional Training

• Fellowship: Kennedy-Krieger Institute, Baltimore, Md.

Professional Highlights

• Howard Hughes Medical Institutes Postdoctoral Fellowship.

Certifications

• Psychiatry and Neurology - Neurology with Special Qualifications in Child Neurology

Specialty Interests

Pseudotumor cerebri, leukodystrophies, lysosomal storage disorders, Pediatric Neurology Child abuse Factitious disorders

Innovations & Patents

• Patent Number 5,998,149.  Issued December 7, 1999.  Inventors: Hsich Gary, Kenney Kimbra, Gibbs Clarence J., and Harrington Michael G.  “Method of detecting transmissible spongiform encephalopathies.”  Patent for the detection of 14-3-3 proteins in the cerebrospinal fluid as a diagnostic tool in Creutzfeldt-Jakob disease.

See publications for Gary Hsich, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/14/2024, Dr. Hsich has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Hsich receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• National Institutes of Health (NIH)

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.